Sale!

EPCAM Gene Colorectal Cancer Hereditary Nonpolyposis Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EPCAM gene colorectal cancer hereditary nonpolyposis type 8 genetic test is a specialized diagnostic procedure offered at DNA Labs UAE. This test is designed to identify mutations in the EPCAM gene, which are linked to an increased risk of developing colorectal cancer as part of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC) type 8. Lynch syndrome is the most common hereditary form of colorectal cancer and can also increase the risk of other types of cancer.

The EPCAM gene plays a crucial role in cell signaling and adhesion, and mutations in this gene can lead to abnormal cell growth and cancer. Identifying individuals with these mutations enables healthcare providers to implement targeted surveillance strategies, early interventions, and personalized treatment plans to manage the increased cancer risk.

The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of EPCAM gene mutations. DNA Labs UAE, known for its state-of-the-art facilities and expertise in genetic testing, offers this test at a cost of 4400 AED. The test is recommended for individuals with a family history of Lynch syndrome or colorectal cancer, as well as those who have personal health histories that suggest an increased risk of these conditions. By providing critical genetic information, the EPCAM gene test is a valuable tool in the prevention and early detection of colorectal cancer and related cancers in at-risk populations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EPCAM Gene Colorectal Cancer Hereditary Nonpolyposis Type 8 Genetic Test

Overview

The EPCAM gene is a gene that provides instructions for making a protein called epithelial cell adhesion molecule. This protein is found on the surface of cells and is involved in cell-to-cell adhesion, which is important for maintaining the structure and function of tissues.

Colorectal cancer, hereditary nonpolyposis type 8 (HNPCC8) is a hereditary condition characterized by an increased risk of developing colorectal cancer and other types of cancer, such as endometrial cancer. HNPCC8 is caused by mutations in the EPCAM gene.

Genetic Test Details

  • Test Name: EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test gene EPCAM

Importance of Genetic Testing

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of colorectal cancer, HNPCC8 NGS genetic testing would involve sequencing the EPCAM gene to identify any mutations or genetic variants that may be associated with an increased risk of developing colorectal cancer.

By identifying mutations in the EPCAM gene, NGS genetic testing can help diagnose individuals with HNPCC8 and guide appropriate management and surveillance strategies for early detection and prevention of colorectal cancer. It can also be used to determine if other family members are at risk of inheriting the mutation and developing cancer.

Conclusion

The EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test offered by DNA Labs UAE is a valuable tool for identifying individuals at risk of developing colorectal cancer and other associated cancers. With its advanced NGS technology, this genetic test provides accurate and reliable results to aid in diagnosis, management, and prevention of HNPCC8. Consult with an oncologist and undergo a genetic counseling session to understand the significance of this test and its implications for you and your family members.

Test Name EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test gene EPCAM
Test Details

The EPCAM gene is a gene that provides instructions for making a protein called epithelial cell adhesion molecule. This protein is found on the surface of cells and is involved in cell-to-cell adhesion, which is important for maintaining the structure and function of tissues.

Colorectal cancer, hereditary nonpolyposis type 8 (HNPCC8) is a hereditary condition characterized by an increased risk of developing colorectal cancer and other types of cancer, such as endometrial cancer. HNPCC8 is caused by mutations in the EPCAM gene.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of colorectal cancer, HNPCC8 NGS genetic testing would involve sequencing the EPCAM gene to identify any mutations or genetic variants that may be associated with an increased risk of developing colorectal cancer.

By identifying mutations in the EPCAM gene, NGS genetic testing can help diagnose individuals with HNPCC8 and guide appropriate management and surveillance strategies for early detection and prevention of colorectal cancer. It can also be used to determine if other family members are at risk of inheriting the mutation and developing cancer.